Hennion & Walsh Asset Management, Inc. Kura Oncology, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.15 Billion
- Q1 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 119,816 shares of KURA stock, worth $726,084. This represents 0.04% of its overall portfolio holdings.
Number of Shares
119,816
Previous 122,915
2.52%
Holding current value
$726,084
Previous $1.07 Million
21.12%
% of portfolio
0.04%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding KURA
# of Institutions
190Shares Held
79MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$47 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$45.1 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$42.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$39.8 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$30 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $405M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...